semaglutide patent novo nordisk Takes Telehealth Company to Court Over Knockoffs Ozempic Patent Expiry Heralds Weight-Loss

, GLP-1 (GLP-1)

November 24, 2025

Medical research shows that abrupt cessation differs significantly from planned dose reduction, making the decision to stop GLP-1 therapy one that requires careful clinical consideration rather than an immediate halt

Chronic and acute intestinal inflammation is associated with alterations in cell proliferation most likely due to tissue insults and IEC loss

Powered by high-purity Glutathione : A potent antioxidant that revitalizes dull skin, evens tone, and restores radiance

After PS matching, no differences were observed in age, sex, height, weight, BMI, eGFR, smoking status, alcohol consumption, or the number of health screening examinations among the three groups